Physician profile
Gerges Azer
NPI 1265964480
$3,304.55
in general payments reported to CMS, 2019-2025
10 companies · $494 in 2025
The $494 reported for 2025 was more than what 91% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,563 · 2023: $682 · 2024: $565 · 2025: $494.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,613 · Travel and Lodging: $129.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,612.84 |
| Travel and Lodging | $128.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,676.13 | 2022-2023 | Kyphon Express II Kyphopak Tray, Intellis Adaptivestim |
| Boston Scientific Corporation | $414.63 | 2023-2025 | Intracept, Intracept Rf Probe, Wavewriter Alpha Prime 16 |
| Spr Therapeutics, INC | $352.42 | 2024-2025 | Sprint Pns System |
| Abbott Laboratories | $296.11 | 2022-2023 | Proclaim |
| Saluda Medical Americas, INC. | $166.31 | 2025 | Evoke |
| Averitas Pharma INC. | $146.28 | 2024 | Qutenza |
| Relievant Medsystems, INC. | $132.01 | 2023 | Intracept |
| Globus Medical, INC. | $51.47 | 2025 | Senza |
| Bioventus LLC | $38.93 | 2025 | Stimrouter Implantable Kit |
| Nevro Corp. | $30.26 | 2024 | Senza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerges Azer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.